{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:31Z","timestamp":1791919051600,"version":"4.3.4"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sapere Aude Program of the Danish Council for Independent Research","award":["0602-01873B"],"award-info":[{"award-number":["0602-01873B"]}]},{"name":"Lundbeck Foundation's Fellowship","award":["R82-A6839"],"award-info":[{"award-number":["R82-A6839"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.expneurol.2016.01.021","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T07:30:57Z","timestamp":1453879857000},"page":"76-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Use of human stem cells in Huntington disease modeling and translational research"],"prefix":"10.1016","volume":"278","author":[{"given":"Monika M.","family":"Golas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.01.021_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11807","article-title":"Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells","volume":"494","author":"Araki","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0020","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1242\/dev.117093","article-title":"Activin A directs striatal projection neuron differentiation of human pluripotent stem cells","volume":"142","author":"Arber","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0030","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1523\/JNEUROSCI.18-06-02118.1998","article-title":"Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor","volume":"18","author":"Arsenijevic","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0035","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1073\/pnas.0808488105","article-title":"Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats","volume":"105","author":"Aubry","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5966\/sctm.2014-0117","article-title":"Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives","volume":"4","author":"Awe","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.neurol.2014.10.007","article-title":"Regenerative medicine in Huntington's disease: current status on fetal grafts and prospects for the use of pluripotent stem cell","volume":"170","author":"Bachoud-Levi","year":"2014","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/exnr.1999.7239","article-title":"Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease","volume":"161","author":"Bachoud-Levi","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0060","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-Levi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/35083081","article-title":"Novel mechanism of wnt signalling inhibition mediated by dickkopf-1 interaction with LRP6\/Arrow","volume":"3","author":"Bafico","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.mcn.2007.11.001","article-title":"Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease","volume":"37","author":"Bantubungi","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease","volume":"84","author":"Barker","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nn.4014","article-title":"A SNP in the HTT promoter alters NF-kappaB binding and is a bidirectional genetic modifier of Huntington disease","volume":"18","author":"Becanovic","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0085","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","article-title":"Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner","volume":"28","author":"Benn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stem.2013.04.014","article-title":"Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease","volume":"12","author":"Benraiss","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018994","article-title":"Adult neurogenesis in humans","volume":"7","author":"Bergmann","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-0102(00)00102-4","article-title":"Characterization of the subventricular zone of the adult human brain: evidence for the involvement of bcl-2","volume":"37","author":"Bernier","year":"2000","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3565(24)38893-7","article-title":"Antisense-mediated down-regulation of the human huntingtin gene","volume":"295","author":"Boado","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00920568","article-title":"Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. network of European CNS transplantation and restoration (NECTAR)","volume":"242","author":"Boer","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1023\/A:1009985223158","article-title":"Ethical issues in neurografting of human embryonic cells","volume":"20","author":"Boer","year":"1999","journal-title":"Theor. Med. Bioeth."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/scd.2010.0120","article-title":"Derivation of Huntington's disease-affected human embryonic stem cell lines","volume":"20","author":"Bradley","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ncomms1817","article-title":"Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors","volume":"3","author":"Cambray","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","article-title":"The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity","volume":"46","author":"Camnasio","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1242\/dev.084608","article-title":"Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons","volume":"140","author":"Carri","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0145","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20111495","article-title":"Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient","volume":"446","author":"Chae","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0155","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1242\/dev.013086","article-title":"Notochord-derived shh concentrates in close association with the apically positioned basal body in neural target cells and forms a dynamic gradient during neural patterning","volume":"135","author":"Chamberlain","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0165","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.1430","article-title":"High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes","volume":"31","author":"Charbord","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0170","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0175","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes","volume":"11","author":"Consortium HD iPSC","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/nature.2014.15915","article-title":"Japanese woman is first recipient of next-generation stem cells","author":"Cyranoski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.111.249243","article-title":"Immunogenicity of pluripotent stem cells and their derivatives","volume":"112","author":"de Almeida","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5966\/sctm.2011-0045","article-title":"Concise review: self-renewal in the central nervous system: neural stem cells from embryo to adult","volume":"1","author":"De Filippis","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12015-013-9441-8","article-title":"Human pluripotent stem cell differentiation into authentic striatal projection neurons","volume":"9","author":"Delli","year":"2013","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0205","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2202-8-36","article-title":"Differential development of neuronal physiological responsiveness in two human neural stem cell lines","volume":"8","author":"Donato","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0215","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099341","article-title":"Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells","volume":"9","author":"Drouet","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0225","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0240","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1089\/scd.2010.0282","article-title":"Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the hedgehog pathway","volume":"20","author":"El-Akabawy","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2202-13-97","article-title":"Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6\/2 transgenic mouse model of Huntington's disease","volume":"13","author":"El-Akabawy","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0092-8674(95)90536-7","article-title":"Sonic hedgehog induces the differentiation of ventral forebrain neurons: a common signal for ventral patterning within the neural tube","volume":"81","author":"Ericson","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0255","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/3305","article-title":"Neurogenesis in the adult human hippocampus","volume":"4","author":"Eriksson","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0260","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2014.01.044","article-title":"Neurogenesis in the striatum of the adult human brain","volume":"156","author":"Ernst","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/nat.2013.0452","article-title":"Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification","volume":"24","author":"Evers","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2013.02.037","article-title":"How induced pluripotent stem cells are redefining personalized medicine","volume":"520","author":"Ferreira","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0280","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/3473","article-title":"Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes","volume":"16","author":"Flax","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2010.08.031","article-title":"Technical factors that influence neural transplant safety in Huntington's disease","volume":"227","author":"Freeman","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nbt.3101","article-title":"Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases","volume":"33","author":"Frock","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0295","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0300","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2183\/pjab.85.348","article-title":"Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome","volume":"85","author":"Fusaki","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0305","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuron.2013.10.037","article-title":"Neural stem cells: generating and regenerating the brain","volume":"80","author":"Gage","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0310","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","author":"Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2009.12.005","article-title":"Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation","volume":"222","author":"Gallina","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2008.06.003","article-title":"Development of human striatal anlagen after transplantation in a patient with Huntington's disease","volume":"213","author":"Gallina","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0330","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0335","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","article-title":"Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells","volume":"12","author":"Guha","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-013-1222-6","article-title":"Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development","volume":"127","author":"Hargus","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0345","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington's disease","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0350","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","article-title":"Cortical and striatal neurone number in Huntington's disease","volume":"88","author":"Heinsen","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0355","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.5966\/sctm.2014-0129","article-title":"Concise review: animal substance-free human embryonic stem cells aiming at clinical applications","volume":"3","author":"Hovatta","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0360","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/stem.436","article-title":"European scientific, ethical, and legal issues on human stem cell research and regenerative medicine","volume":"28","author":"Hovatta","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2009.04975.x","article-title":"Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA","volume":"1175","author":"Hu","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0370","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"Hu","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126860","article-title":"Three Huntington's disease specific mutation-carrying human embryonic stem cell lines have stable number of CAG repeats upon In Vitro differentiation into cardiomyocytes","volume":"10","author":"Jacquet","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0380","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0385","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1179\/016164110X12816242542571","article-title":"Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model","volume":"33","author":"Jiang","year":"2011","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0390","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0395","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/mt.2015.128","article-title":"Huntingtin haplotypes provide prioritized Target panels for allele-specific silencing in Huntington disease patients of European ancestry","volume":"23","author":"Kay","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cge.12385","article-title":"Personalized gene silencing therapeutics for Huntington disease","volume":"86","author":"Kay","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0405","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0410","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1098\/rstb.1971.0102","article-title":"The structure of the caudate nucleus of the cat: light and electron microscopy","volume":"262","author":"Kemp","year":"1971","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0415","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","article-title":"Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis","volume":"12","author":"Kennedy","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0420","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nsb1196-940","article-title":"A 2.2A resolution crystal structure of a designed zinc finger protein bound to DNA","volume":"3","author":"Kim","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0425","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/neu.480250705","article-title":"FGF and EGF are mitogens for immortalized neural progenitors","volume":"25","author":"Kitchens","year":"1994","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0430","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exnr.1997.6685","article-title":"Safety of intrastriatal neurotransplantation for Huntington's disease patients","volume":"149","author":"Kopyov","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0435","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0440","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0445","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1242\/dev.036624","article-title":"Coordination of sonic hedgehog and wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells","volume":"136","author":"Li","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0450","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5966\/sctm.2014-0083","article-title":"In Vitro differentiation of human neural progenitor cells into striatal GABAergic neurons","volume":"4","author":"Lin","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0455","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1634\/stemcells.2005-0324","article-title":"A new era in the ethics of human embryonic stem cell research","volume":"23","author":"Lo","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0460","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1073\/pnas.90.5.2074","article-title":"Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia","volume":"90","author":"Lois","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0465","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0470","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5966\/sctm.2012-0029","article-title":"Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent","volume":"1","author":"Lowenthal","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0475","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","article-title":"Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice","volume":"10","author":"Ma","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0480","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0485","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.346.6206.237","article-title":"A latent neurogenic program in astrocytes regulated by notch signaling in the mouse","volume":"346","author":"Magnusson","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0490","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11689-009-9035-6","article-title":"Role for TGF-beta superfamily signaling in telencephalic GABAergic neuron development","volume":"2","author":"Maira","year":"2010","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0495","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1126\/science.1216211","article-title":"The crystal structure of TAL effector PthXo1 bound to its DNA target","volume":"335","author":"Mak","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0500","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0505","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0510","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00230496","article-title":"The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy","volume":"85","author":"Mann","year":"1993","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0515","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev-cellbio-100913-013116","article-title":"The nature of embryonic stem cells","volume":"30","author":"Martello","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0520","first-page":"6","article-title":"Large-sized Fetal Striatal Grafts in Huntington's Disease Do Stop Growing: Long-term Monitoring in the Florence Experience","author":"Mascalchi","year":"2014","journal-title":"PLoS Curr."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0525","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/humrep\/dei345","article-title":"Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders","volume":"21","author":"Mateizel","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0530","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.drudis.2012.01.006","article-title":"Allele-selective inhibition of trinucleotide repeat genes","volume":"17","author":"Matsui","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0535","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-Derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0540","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jcb.24432","article-title":"Stem cell-based therapy for Huntington's disease","volume":"114","author":"Maucksch","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0545","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/1535370214522936","article-title":"Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells","volume":"239","author":"Maynard","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0550","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nbt1319","article-title":"An improved zinc-finger nuclease architecture for highly specific genome editing","volume":"25","author":"Miller","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0555","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0560","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0565","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1574888X09666140321115803","article-title":"Human fetal striatum-derived neural stem (NS) cells differentiate to mature neurons in vitro and in vivo","volume":"9","author":"Monni","year":"2014","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0570","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jnr.490250404","article-title":"Fibroblast growth factor stimulates the proliferation and differentiation of neural precursor cells in vitro","volume":"25","author":"Murphy","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0575","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","article-title":"Huntington's disease genetics","volume":"1","author":"Myers","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0580","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0585","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/stem.177","article-title":"Long-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum","volume":"27","author":"Nasonkin","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0590","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mcne.2000.0872","article-title":"Inhibition of Huntington synthesis by antisense oligodeoxynucleotides","volume":"16","author":"Nellemann","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0595","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1472-6483(10)60053-3","article-title":"Human embryonic stem cell models of Huntington disease","volume":"19","author":"Niclis","year":"2009","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0600","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0605","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1093\/nar\/gkt725","article-title":"Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant huntingtin in the CNS","volume":"41","author":"Ostergaard","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0610","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0615","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0006-8993(84)91224-1","article-title":"The striatopallidal and striatonigral projections: two distinct fiber systems in primate","volume":"303","author":"Parent","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0620","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0625","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0630","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0635","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/stem.2112","article-title":"Concise review: patient-Derived Stem Cell Research for Monogenic Disorders","volume":"34","author":"Qin","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0640","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0645","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","article-title":"Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease","volume":"79","author":"Reuter","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0650","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","article-title":"Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system","volume":"255","author":"Reynolds","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0655","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10761","article-title":"The promise of induced pluripotent stem cells in research and therapy","volume":"481","author":"Robinton","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0660","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0665","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddu204","article-title":"Human-induced pluripotent stem cells: potential for neurodegenerative diseases","volume":"23","author":"Ross","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0670","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0675","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0680","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.expneurol.2011.12.045","article-title":"Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease","volume":"234","author":"Sadan","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0685","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature02301","article-title":"Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration","volume":"427","author":"Sanai","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0690","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","article-title":"A comparison of non-integrating reprogramming methods","volume":"33","author":"Schlaeger","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0695","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.trsl.2010.07.002","article-title":"Translation of stem cell therapy for neurological diseases","volume":"156","author":"Schwarz","year":"2010","journal-title":"Transl. Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA that distinguish between genes that differ by a single nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0705","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/hmg\/ddm054","article-title":"Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain","volume":"16","author":"Shelbourne","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0710","doi-asserted-by":"crossref","first-page":"34880","DOI":"10.1074\/jbc.M804183200","article-title":"Huntingtin regulates RE1-silencing transcription factor\/neuron-restrictive silencer factor (REST\/NRSF) nuclear trafficking indirectly through a complex with REST\/NRSF-interacting LIM domain protein (RILP) and dynactin p150 glued","volume":"283","author":"Shimojo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0715","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1566524011313050010","article-title":"Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine","volume":"13","author":"Shtrichman","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0720","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.trsl.2013.01.001","article-title":"Pluripotent stem cells and gene therapy","volume":"161","author":"Simara","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients","volume":"9","author":"Skotte","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0730","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2014.226","article-title":"Efficient and allele-specific genome editing of disease loci in human iPSCs","volume":"23","author":"Smith","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0735","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.cell.2013.05.002","article-title":"Dynamics of hippocampal neurogenesis in adult humans","volume":"153","author":"Spalding","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0740","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1471-4159.2003.01624.x","article-title":"cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1)","volume":"84","author":"Stachowiak","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0745","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0750","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0755","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1574888X113086660068","article-title":"Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives","volume":"9","author":"Tan","year":"2014","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0760","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1574888X09666140923101110","article-title":"Mesenchymal stem cells: potential in treatment of neurodegenerative diseases","volume":"9","author":"Tanna","year":"2014","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0765","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(94)90280-1","article-title":"Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy","volume":"343","author":"Taylor-Robinson","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0770","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","article-title":"Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm","volume":"6","author":"Telenius","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0775","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/340471a0","article-title":"Division and differentiation of isolated CNS blast cells in microculture","volume":"340","author":"Temple","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0780","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0785","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jmg.31.5.377","article-title":"Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset","volume":"31","author":"Trottier","year":"1994","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0790","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0795","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5966\/sctm.2013-0038","article-title":"Isolation of neural progenitor cells from the human adult subventricular zone based on expression of the cell surface marker CD271","volume":"3","author":"van Strien","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0800","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1472-6483(10)60810-3","article-title":"Human embryonic stem cell lines with genetic disorders","volume":"10","author":"Verlinsky","year":"2005","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0805","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","article-title":"Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts","volume":"84","author":"Victor","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0810","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0815","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0820","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington's disease: what's in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043099","article-title":"Creation of an open-access, mutation-defined fibroblast resource for neurological disease research","volume":"7","author":"Wray","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0830","doi-asserted-by":"crossref","first-page":"10454","DOI":"10.1523\/JNEUROSCI.23-32-10454.2003","article-title":"Chromosome segregation defects contribute to aneuploidy in normal neural progenitor cells","volume":"23","author":"Yang","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0835","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1038\/ncomms5240","article-title":"Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-cas platform","volume":"5","author":"Yoshimi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0840","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0845","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuropharm.2008.09.019","article-title":"Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation","volume":"56","author":"Yu","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0850","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0855","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2016.01.021_bb0860","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0865","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.01.021_bb0870","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616300206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616300206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T07:14:40Z","timestamp":1748762080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616300206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":174,"alternative-id":["S0014488616300206"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.01.021","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of human stem cells in Huntington disease modeling and translational research","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}